Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials
Bharat Biotech develop's India's first Covid-19 vaccine candidate with ICMR-NIV, gets DCGI nod for human trials
IndiaTimes
0 shares
1 views
You might like
Related news coverage
DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine
Mid-Day
New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to..
-
India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials
Fossbytes
-
India's first COVID-19 vaccine candidate cleared for human trials
Al Jazeera
-
India’s first Covid-19 vaccine candidate by Hyderabad-based Bharat Biotech set for trials
IndiaTimes
-
Hyderabad company develops India’s first DCGI-approved vaccine candidate, gets nod for human trials
IndiaTimes
Advertisement
More coverage
Corrupt Propositions: AstraZeneca, Public Institutions And The Coronavirus Vaccine Drive – OpEd
Putting your destiny into the hands of a drug company is much like seeking reassurances from an opportunistic pimp. The returns..
Eurasia Review